|
Georgia College
of Veterinary Medicine,
The University of Georgia |
GLYCOSYLATION OF RECOMBINANT PORCINE ZONA PELLUCIDA. The zona pellucida surrounding the mammalian oocyte is
a nutritive and protective paracrystalline matrix. Glycosylation of the
zona pellucida is involved with sperm-egg interaction by providing sperm
binding sites. The porcine zonae is comprised of three major glycoproteins:
ZP1; ZP3?? and ZP3?. ZP3? and ZP3? are involved with sperm binding and
stabilization of the sperm-egg interaction. An antigen that initiates
an immune response against these carbohydrate moieties could mechanically
disrupt the sperm-egg interaction. Recombinant proteins modeled after
pZP3? and pZP3? are, therefore, produced as a potential immunocontraceptive.
The recombinant porcine zona pellucida vaccine is produced using Trichoplusia
ni- High FiveTM insect cell lines. While the genetic information for the
protein component of the ZP is encoded in the transfected plasmid, carbohydrate
moieties are added in the ER and modified in the secretory pathway. This
experiment will determine if recombinant protein undergoes the same post-translational
glycosylation in insect cells as in porcine cells. We established cell
cultures that synthesize recombinant protein. To conduct carbohydrate
composition analysis, we produced ~600mg of each pZP3? and pZP3?. The
harvested protein was purified and analyzed using Roche DIG Glycan Detection
Kit, an immunoassay. Once we affirmed the presence of glycoconjugates
on the recombinant protein, the samples were electrophoresed, transferred
to PVDF membranes and stained. The recombinant bands were then cut from
the membrane and analyzed by Dr. Roberta Merkle at CCRC to determine:
(i) molar ratio of individual sugars to protein; (ii) class of the oligosaccharides
present. Knowing the glycosyl composition of the recombinant glycoprotein
may elucidate carbohydrate roles in the sperm-egg interaction by allowing
comparison of recombinant to native porcine ZP glycosylation and comparison
of immunogenicity of recombinant with native vaccine. |
Georgia Veterinary Scholar |